Major advances in bioengineered heart implants.
'Tissue engineering' (TE) and 'regenerative medicine' (RM) will be at the core of heart surgery in the future. An EU initiative generated a platform of expertise to supply top-class training for researchers to enable development of bioengineered cardiovascular implants.
| Published in: | Research'eu results magazine July, 64 (2017). |
|---|---|
| Format: | Article |
| Language: | English |